Clinical trial
Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria
NCT00486694 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00486694 |
|---|---|
| Title | Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria |
| Official title | A Randomised Non-Inferiority Trial of Sulfadoxine-Pyrimethamine Plus Artesunate Compared to Chloroquine for the Treatment of Vivax Malaria in Eastern Afghanistan. |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria, Vivax |
| Intervention type | Drug |
| Interventions | Sulfadoxine-pyrimethamine + artesunate, Chloroquine |
| Enrollment | 190 |
| Start date | Mar 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Jun 15, 2007 |
| Last update posted | Jun 15, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: